Cencora, Inc. $COR Shares Acquired by Assetmark Inc.

Assetmark Inc. lifted its position in Cencora, Inc. (NYSE:COR) by 23.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 42,850 shares of the company’s stock after purchasing an additional 8,016 shares during the quarter. Assetmark Inc.’s holdings in Cencora were worth $13,392,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Norges Bank purchased a new position in Cencora during the 2nd quarter worth approximately $695,215,000. Mizuho Markets Americas LLC increased its stake in shares of Cencora by 116.4% in the third quarter. Mizuho Markets Americas LLC now owns 212,800 shares of the company’s stock worth $66,506,000 after acquiring an additional 1,511,906 shares during the period. Artisan Partners Limited Partnership purchased a new position in shares of Cencora during the second quarter worth $411,888,000. Vanguard Group Inc. lifted its position in Cencora by 5.3% during the second quarter. Vanguard Group Inc. now owns 22,479,041 shares of the company’s stock valued at $6,740,340,000 after purchasing an additional 1,125,661 shares during the period. Finally, Viking Global Investors LP boosted its holdings in Cencora by 95.0% in the second quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock valued at $624,207,000 after purchasing an additional 1,013,913 shares during the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Insiders Place Their Bets

In other Cencora news, EVP Silvana Battaglia sold 1,677 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $345.00, for a total transaction of $578,565.00. Following the sale, the executive vice president owned 18,796 shares in the company, valued at $6,484,620. This represents a 8.19% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Elizabeth S. Campbell sold 3,351 shares of Cencora stock in a transaction on Friday, December 19th. The stock was sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the sale, the executive vice president directly owned 23,891 shares of the company’s stock, valued at approximately $8,173,111.10. This trade represents a 12.30% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 20,316 shares of company stock worth $7,151,265 over the last ninety days. Corporate insiders own 0.38% of the company’s stock.

Cencora Stock Performance

Shares of NYSE:COR opened at $360.59 on Monday. The business’s 50 day moving average price is $347.51 and its 200-day moving average price is $328.88. The company has a debt-to-equity ratio of 3.62, a current ratio of 0.92 and a quick ratio of 0.51. The firm has a market capitalization of $70.15 billion, a PE ratio of 43.34, a P/E/G ratio of 1.66 and a beta of 0.68. Cencora, Inc. has a 1 year low of $237.71 and a 1 year high of $377.54.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The company had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. During the same quarter in the prior year, the company earned $3.73 EPS. Cencora’s revenue was up 5.5% compared to the same quarter last year. As a group, equities research analysts expect that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Investors of record on Friday, February 13th will be issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date is Friday, February 13th. Cencora’s payout ratio is 28.85%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on COR shares. Evercore reduced their price objective on Cencora from $440.00 to $420.00 and set an “outperform” rating for the company in a research note on Thursday, February 5th. JPMorgan Chase & Co. lifted their price target on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Jefferies Financial Group upgraded Cencora from an “underperform” rating to a “buy” rating in a research report on Thursday, January 22nd. TD Cowen lifted their target price on shares of Cencora from $350.00 to $400.00 and gave the company a “buy” rating in a report on Monday, November 10th. Finally, Robert W. Baird set a $415.00 price target on shares of Cencora in a report on Tuesday, January 13th. Eleven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Cencora presently has a consensus rating of “Moderate Buy” and a consensus price target of $399.00.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.